Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Plos Pathogens|October 18, 2019
Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responsesKoen Sedeyn, Bert Schepens, Xavier Saelens
Current Opinion in Immunology|April 10, 2018
Vaccine options for influenza: thinking smallBert Schepens, Dorien De Vlieger, Xavier Saelens
Expert Review of Vaccines|September 23, 2016
M2-based influenza vaccines: recent advances and clinical potentialAnnasaheb Kolpe, Bert Schepens, Walter Fiers, et al.
Expert Review of Vaccines|February 19, 2013
Hepatitis B core-based virus-like particles to present heterologous epitopesKenny Roose, Sarah De Baets, Bert Schepens, et al.
Trends in Microbiology|October 22, 2017
Clinical Potential of Prefusion RSV F-specific AntibodiesIebe Rossey, Jason S McLellan, Xavier Saelens, et al.
Journal of Biotechnology|February 17, 2019
A two-amino acid mutation in murine IgA enables downstream processing and purification on staphylococcal superantigen-like protein 7Shruti Bakshi, Ann Depicker, Bert Schepens, et al.
Journal of Virology|September 28, 2012
Interferon-inducible protein Mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assemblyJudith Verhelst, Eef Parthoens, Bert Schepens, et al.
Antiviral Research|September 5, 2018
Passively transferred M2e-specific monoclonal antibody reduces influenza A virus transmission in miceAnnasaheb Kolpe, Bert Schepens, Liang Ye, et al.
Nucleic Acids Research|January 7, 2006
The polypyrimidine tract-binding protein stimulates HIF-1alpha IRES-mediated translation during hypoxiaBert Schepens, Sandrine A Tinton, Yanik Bruynooghe, et al.
Pageof 6